Pharma major Lupin's stock price has rallied 70 percent from the lows of March 2020. The company is scheduled to report its Q3FY21 earnings on Thursday (28 January). CNBC-TV18 expects the revenue to grow around 7 percent. Margins are expected to improve to 17 percent versus 11.4 percent on a year-on-year basis. Profit is likely to come in around Rs 300 crore.
CNBC-TV18's Ekta Batra has more details on key expectations from Lupin's third quarter or Q3FY21 results on Thursday.Watch the video for more.